reSee.it - Related Video Feed

There are concerns about the long-term side effects of modifying DNA and RNA to enable the production of antibodies. The potential for causing mutations or other risks in the future is uncertain.

The speaker discusses the use of mRNA in food and mentions a presentation about genetically engineering mosquitoes to deliver vaccines through mosquito bites. They mention that the Gates Foundation is funding this research, although they don't have proof of its viability. The speaker clarifies that they are not suggesting that the mosquitoes are currently injecting anyone with anything, but they have evidence that efforts are being made to enable mosquito injections.

A gene drive is described as a mechanism that guarantees a specific gene will be inherited. It attaches to the chosen gene and is introduced into the organism. The concept begins with the fact that a single gene can have different versions, and each organism possesses two copies of every gene. Under normal circumstances, when parents carry different versions of a gene, each version is inherited by only half of the offspring, following traditional Mendelian inheritance. With a gene drive, the inheritance pattern changes: when parents have different versions of the gene, essentially all offspring will inherit the gene with the drive. This effect persists generation after generation, continuing to bias inheritance in favor of the drive-carrying gene. The gene drive contains instructions for a molecular tool that is designed to target the other versions of the chosen gene. This tool scans the organism’s DNA to locate the other versions of the gene. Once it finds a different version, the tool cuts it out, creating a gap or “hole” in the DNA where the other version used to be. After the cut, the organism’s cellular machinery uses the gene with the gene drive as a template to repair the hole. As a result of this repair process, the organism ends up with two copies of the gene that contains the drive, rather than one copy with the drive and one without. This duplication ensures that the drive-carrying gene is the version passed on to the next generation, reinforcing the drive’s presence in the population across generations. In summary, a gene drive biases inheritance so that nearly all offspring inherit the drive, by using a molecular tool to cut other gene versions and repair the DNA with the drive-containing gene as the template, thereby converting heterozygous individuals into homozygous drive carriers and ensuring two copies are passed forward.

CRISPR, a lab technique, can alter mosquito DNA to decrease their population or prevent them from carrying parasites. Discussions are underway with African countries to determine the necessary tests and trials before implementing this technique. Although it will take several years to obtain country approvals, the potential to reduce mosquito populations and eliminate malaria locally is promising. The speaker even brought some mosquitoes to the auditorium to provide firsthand experience. They emphasize that it is unfair for only poor people to face this issue.

In Medellin, Colombia, the world's largest mosquito factory is producing 30 million mosquitoes per week for the World Mosquito Program. By introducing Wolbachia bacteria into the mosquitoes, their ability to transmit diseases like dengue is stopped. The process involves releasing Wolbachia-infected mosquitoes into the wild population through mating. The factory houses mosquito eggs, larvae, and pupae, which are sorted by sex to manipulate the sex ratio. The mosquitoes are fed blood and then either packaged as eggs or released as adults into the field. With over half the world's population at risk of these diseases, the goal is to scale and deliver this solution to communities in need.

The symposium covers the potential safety and threat of “replicating” vaccines, especially LepriCon (leprecon) vaccines, in the context of Covid-19 vaccines and genome‑editing concepts. The speakers present a chain of claims and concerns, some drawing on reports and others presenting theories about how these next‑generation vaccines could behave in humans and populations. Key points and claims presented - Emerging mechanisms and risks: The panel notes that blood vessel inflammation and thrombosis mechanisms are increasingly observed, including in vaccine contexts, with examples from individuals who needed limb amputation and others who developed severe vascular events after vaccination. One case involved a 70‑year‑old man who, after a third dose, developed embolic events necessitating shoulder joint surgery, and another where a 60‑year‑old man developed acute limb ischemia and died; both are presented as suggesting a serious vascular mechanism linked to vaccination, though causal connections are not established. - Replicating/vector vaccines and their concerns:荒川博士 and others discuss LepiCon vaccines as vaccines that replicate inside the body. The concept involves “replicating viral vectors” where the genome can mutate and evolve during replication. The green‑highlighted segment in a slide (the antigen gene) plus a blue/orange segment (replicating gene cassette) is used to describe how LepriCon vaccines are designed to carry viral genes and replicate, with the assertion that replication, mutation, and recombination can occur, potentially generating new variants inside the host. - Differences from conventional vaccines: The discussion contrasts LepriCon vaccines with standard mRNA vaccines. In conventional mRNA vaccines, messenger RNA is delivered and translated into antigen proteins, then degraded; in LepriCon vaccines, replicating RNA/DNA can persist and continue producing antigen, with mutation and recombination possible. The panel emphasizes that LepriCon vaccines use replicating/copying mechanisms and that the genetic material can be copied in ways that differ from natural human biology, potentially creating unpredictable variants. - Central dogma and exceptions: The speakers reference the central dogma (DNA → RNA → protein) but note exceptions in viruses, including RNA viruses that can reverse‑transcribe to DNA (retroviruses) and RNA viruses that replicate RNA directly. They discuss how LepriCon vaccines would rely on replicative processes that do not follow the usual linear flow and why this could complicate predictions about safety and behavior in humans. - Potential for unintended spread and environmental impact: A major concern raised is that self‑replicating vectors could spread beyond the vaccinated individual, via exosomes or other intercellular transport, creating secondary infections or non‑target spread. Exosomes could ferry replicating genetic material, raising fears of new infection chains or “outbreaks” stemming from the vaccine itself, and even suggesting the possibility of vaccination‑induced spread akin to an attenuated or modified pathogen. - Safety signals and immunology concerns: The discussion touches on immune system risks, including immune dysregulation, autoimmune phenomena, and unexpected inflammatory responses. IGG4‑related disease is highlighted as a potential adverse outcome post‑vaccination, with descriptions of glandular and systemic involvement and the idea that high IGG4 levels could have immunosuppressive effects that alter responses to infection or vaccination. The panel notes observed increases in certain immunoglobulin subclasses after multiple LepriCon doses and discusses the possibility of immune tolerance or enhanced immune responses that could be harmful. - Historical and theoretical context: References are made to past epidemics and speculative pandemics caused by misused or dangerous vaccine platforms, drawing on central molecular biology concepts and historical anecdotes about how vaccines can be designed and misused. The discussion frames LepriCon vaccines as a high‑risk platform that could, in theory, generate recombinants, escape mutations, or cause unintended immune and inflammatory consequences. - Clinical and regulatory implications: The speakers call for caution, arguing that more evidence is needed before approving or widespread use of LepriCon vaccines. They emphasize the need for long‑term observation and transparent communication about risks, and criticize the potential for insufficient understanding among healthcare workers and the public. They also urge that any future vaccine development should consider the possibility of genome editing, recombination, and exosome‑mediated spread, and stress the importance of not underestimating possible adverse effects. - Real‑world observations and skepticism about hype: Several speakers underscore that the danger is not merely hypothetical; there are reports of adverse events, including stroke‑like conditions, inflammatory diseases, and immune dysregulation in vaccinated individuals. They stress that the evolution and mutation of replicating vaccines could outpace current surveillance methods, and that “information manipulation” or lack of transparent reporting could mislead the public about risks. - Final reflections and call to action: The concluding messages advocate recognizing the potential failures of messenger RNA vaccines and acknowledging that both conventional and replicating platforms may carry risks. The speakers urge ongoing critical analysis, cautious progression, and robust verification of claims through transparent, independent investigation. They close with thanks to the organizers and a hope that the discussion may contribute to broader public awareness and informed decision‑making. Notable emphasis and unique considerations - The core concern centers on LepriCon vaccines’ replication, mutation, and potential to spread beyond the vaccinated person; exosome transport and genomic/cellular integration are highlighted as mechanisms that could generate new risks not present with non‑replicating vaccines. - The discussion stresses that IGG4 responses could become alarmingly high after certain doses, potentially leading to immunosuppressive effects or autoimmune phenomena, and presents IGG4‑related disease as a potential complication to monitor. - The speakers insist that safety and transparency are paramount, and that misinformation or optimistic narratives about rapid vaccine development could lead to harm if new platforms are adopted without comprehensive evaluation. Overall, the symposium foregrounds cautious scrutiny of replicating vaccine platforms, frames potential biological and regulatory risks, and calls for careful, evidence‑based assessment before broader deployment.

We are discussing regulation and the use of CRISPR to reduce mosquito populations and combat malaria. We are working with African countries on necessary trials. It will take time to get approvals, but the potential to eliminate disease locally is promising. Malaria is transmitted by mosquitoes, and we are demonstrating this by releasing some in the auditorium. Everyone should understand the impact, not just the poor.

There are concerns about the long-term effects of modifying people's DNA and RNA to encode the ability to produce antibodies. The potential risks include mutations and other unknown consequences.

The speaker states that mRNA in food is a critical issue, but also highlights the potential for transgenic mosquitoes to deliver vaccines via saliva. They reference a presentation about producing a transgenic mosquito as a "flying syringe" to deliver protective vaccines. The speaker claims the Gates Foundation is funding genetic engineering of mosquitoes with the intention of using mosquito bites for vaccination. While they don't have definitive proof of its viability, they assert that this research is underway. The speaker clarifies they are not claiming current mosquitoes are injecting people with anything. However, they state they have indisputable evidence that efforts are being made to enable mosquitoes to inject people with substances in the future.

There is a technique called CRISPR in the lab that can manipulate mosquito DNA to reduce their population or eliminate the disease they carry. Discussions are ongoing with African countries to determine the necessary tests and trials before implementing this solution. However, obtaining country approvals will take several years. Despite the time frame, the potential of reducing mosquito population and eradicating the disease locally makes this approach highly promising.

In Medellin, Colombia, the world's largest mosquito factory is producing 30 million mosquitoes per week for the World Mosquito Program. They are using Wolbachia bacteria to prevent the transmission of diseases like dengue, Zika, and chikungunya. The process involves introducing Wolbachia into the mosquitoes, which then pass it on to the wild mosquito population through mating. The factory houses mosquito eggs, larvae, and pupae, which are sorted by sex to manipulate the sex ratio in the cages. The mosquitoes are fed blood and can be released into the field either as eggs or as adults. The program aims to scale and deliver this solution to communities worldwide.

Human engineering has the potential to solve major global issues like climate change. For instance, reducing meat consumption could greatly benefit the planet, but many people are unwilling to give it up due to their weakness of will. However, through human engineering, we could make individuals intolerant to certain types of meat by manipulating their biology. An example of this is the long star tick, which, when it bites, can cause meat allergies. By applying similar principles, we can use human engineering to tackle significant world problems.

A billion genetically modified mosquitoes are being released in the Florida Keys to combat diseases like dengue, yellow fever, and Zika. This is the first time such mosquitoes are being released in the US. The British biotech company, Oxitec, obtained permission from the EPA to release them across 6,000 acres in Florida and Texas. However, a 2019 Yale University study warned that this plan could have unintended consequences. It suggested that the release of these mosquitoes could lead to the creation of hybrid mosquito babies that are more resistant to insecticides, potentially worsening the spread of diseases. The potential risks raise concerns about the success of this initiative.

Genetically modified mosquitoes approved for release in the US mate with females, causing their offspring to die. The program aims to vaccinate people without consent by using mosquitoes as "flying syringes." Concerns arise from the use of partially true narratives to introduce GMO insects, with potential implications for involuntary vaccinations.

People eating too much meat is a problem for the planet, but many are unwilling to give it up due to weakness of will. One solution could be using human engineering to make people intolerant to certain types of meat, similar to how some are intolerant to milk or crayfish. An example of this is the long star tick, which can make people allergic to meat if it bites them. Through human engineering, we have the potential to address significant global issues.

Researchers are conducting research on injecting mosquitoes with vaccines, which the speakers find concerning. They question the containment of these mosquitoes once released and express worries about the potential negative consequences, citing previous instances of invasive species. The modified mosquitoes have already been released in Florida, and the speakers mention the occurrence of malaria cases in Florida and Texas. They express concern about the decision-making process and the potential widespread impact of these mosquitoes. They criticize the idea of blindly trusting the researchers and highlight the need for public discussion and political involvement. The speakers liken the situation to a horror movie plot.

Human engineering has the potential to solve major global issues like climate change. For instance, reducing meat consumption could greatly benefit the planet, but many people are unwilling to give it up due to a weakness of will. However, through human engineering, we could make individuals intolerant to certain types of meat, similar to how some people are intolerant to milk or crayfish. An example of this is the long star tick, which can make people allergic to meat. By utilizing human engineering, we can address significant world problems.

In 1956, the US military released Aedes aegypti mosquitoes infected with the malaria virus in Savannah, Georgia as part of Operation Big Buzz. Now, the military is testing genetically modified mosquitoes to deliver vaccinations, funded by the Bill and Melinda Gates Foundation. However, some residents are concerned about the potential risks and lack of scientific investigation. Similar efforts are being made in Houston to combat the Zika virus. Meanwhile, Oxford University has developed a vaccine that could reduce malaria deaths by 70% by 2030. In Fresno, California, a project is releasing a million mosquitoes per week to reduce the population. In Medellin, Colombia, Wolbachia-infected mosquitoes are being released to control diseases like dengue.

In this video, the speaker discusses the challenges of eradicating malaria and the potential use of genetically modified mosquitoes to deliver vaccines. They express concerns about the spread of malaria if the genetic modification fails and question the ethical implications of releasing modified mosquitoes without informed consent. Another speaker highlights the importance of considering climate change and its impact on the geographic range of disease-carrying mosquitoes. They emphasize the need to prevent, prepare for, and respond to emerging pathogens, using the systems and tools developed for COVID-19 as examples. The speaker also mentions the efforts made by countries to strengthen their healthcare systems for various diseases.

The speaker cautions that we don’t know the long-term side effects of modifying people’s DNA and RNA to directly encode the ability to produce antibodies, and whether that causes other mutations or downstream risks.

CRISPR is a molecular tool that allows for precise genetic editing. Since its introduction in 2012, it has been used to modify various species, including potentially spreading alterations through wild organisms. Malaria is a highly destructive disease, causing the death of 400,000 children annually. Scientists propose using CRISPR to disable or eliminate the mosquito species that transmit malaria, as it is a more effective solution than widespread DDT spraying. Despite potential risks, the severity of malaria outweighs any possible negative consequences, making it a worthwhile endeavor.

Human engineering has the potential to solve major global issues like climate change. For instance, reducing meat consumption could greatly benefit the planet, but many people are unwilling to give up meat due to their weakness of will. However, by using human engineering, we could make individuals intolerant to certain types of meat, similar to how some people are intolerant to milk or crayfish. An example of this is the long star tick, which can make people allergic to meat if it bites them. Through human engineering, we can tackle significant world problems.

Researchers at the Bill Gates Foundation-backed Leiden University Medical Center are developing genetically modified mosquitoes to deliver malaria vaccines. A recent study showed that 8 out of 9 participants who received bites from one type of modified mosquito were protected against malaria, while those in the placebo group received no protection. Despite safety concerns and ethical issues regarding informed consent, the research continues, with plans for larger trials and potential applications for other diseases. Meanwhile, an Australian regulatory body is reviewing an application to release genetically modified mosquitoes to combat dengue fever. The implications of using insects as vaccine carriers raise significant ethical questions, and there are ongoing calls for accountability regarding these experiments.

Transgenic lettuce is being developed to produce mRNA vaccines. The idea is to genetically engineer lettuce and spinach so that consuming them can provide vaccination against biological threats. However, there are scientific problems and potential health risks associated with this proposal. Moreover, it is part of a broader plan to bypass informed consent by incorporating mRNA gene technology into food. Another concerning concept is self-spreading vaccines, where respiratory viruses carry the vaccine and infect others. These proposals are seen as dangerous, reckless, and ethically and scientifically unsound.